Reliability and sensitivity to change of the Bristol Rheumatoid Arthritis Fatigue scales

被引:45
作者
Dures, Emma K. [1 ]
Hewlett, Sarah E. [1 ]
Cramp, Fiona A. [1 ]
Greenwood, Rosemary [2 ]
Nicklin, Joanna K. [1 ]
Urban, Marie [2 ]
Kirwan, John R. [3 ]
机构
[1] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England
[2] Univ Hosp Bristol, Res Design Serv, Bristol, Avon, England
[3] Univ Bristol, Fac Med & Dent, Bristol, Avon, England
关键词
rheumatoid arthritis; fatigue; patient-reported outcome; reliability; sensitivity; MCID; PATIENT-REPORTED OUTCOMES; VISUAL ANALOG SCALES; CULTURAL-ADAPTATION; SELF-MANAGEMENT; HEALTH-STATUS; ASSOCIATION; EXPERIENCE; AGREEMENT; IMPACT;
D O I
10.1093/rheumatology/ket218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine the reliability (stability) and sensitivity of the Bristol Rheumatoid Arthritis Fatigue scales (BRAFs) and patient-reported outcome measures (PROMs) developed to capture the fatigue experience. The Multi-Dimensional Questionnaire (BRAF-MDQ) has a global score and four subscales (Physical Fatigue, Living with Fatigue, Cognitive Fatigue and Emotional Fatigue), while three numerical rating scales (BRAF-NRS) measure fatigue Severity, Effect and Coping. Methods. RA patients completed the BRAFs plus comparator PROMs. Reliability (study 1): 50 patients completed questionnaires twice. A same-day test-retest interval (minimum 60 min) ensured both time points related to the same 7 days, minimizing the capture of fatigue fluctuations. Reliability (study 2): 50 patients completed the same procedure with a re-worded BRAF-NRS Coping. Sensitivity to change (study 3): 42 patients being given clinically a single high dose of i.m. glucocorticoids completed questionnaires at weeks 0 and 2. Results. The BRAF-MDQ, its subscales and the BRAF-NRS showed very strong reliability (r = 0.82-0.95). BRAF-NRS Coping had lower moderate reliability in both wording formats (r = 0.62, 0.60). The BRAF-MDQ, its subscales and the BRAF-NRS Severity and Effect were sensitive to change, with effect sizes (ESs) of 0.33-0.56. As hypothesized, the BRF-NRS Coping was not responsive to the pharmaceutical intervention (ES 0.05). Preliminary exploration suggests a minimum clinically important difference of 17.5% for improvement and 6.1% for fatigue worsening. Conclusion. The BRAF scales show good reliability and sensitivity to change. The lack of BRAF-NRS Coping responsiveness to medication supports the theory that coping with fatigue is a concept distinct from severity and effect that is worth measuring separately.
引用
收藏
页码:1832 / 1839
页数:8
相关论文
共 43 条
[1]  
[Anonymous], 2009, Guidance for industry: Patient-Reported outcome measures: Use in medical product development to support labeling claims
[2]  
[Anonymous], 1992, REVISED MANUAL PROFI
[3]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[4]  
Beaton DE, 2001, ARTHRIT RHEUM-ARTHR, V45, P270, DOI 10.1002/1529-0131(200106)45:3<270::AID-ART260>3.0.CO
[5]  
2-T
[6]   Guidelines for the process of cross-cultural adaptation of self-report measures [J].
Beaton, DE ;
Bombardier, C ;
Guillemin, F ;
Ferraz, MB .
SPINE, 2000, 25 (24) :3186-3191
[7]  
BELZA BL, 1995, J RHEUMATOL, V22, P639
[8]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[9]  
Cella D, 2005, J RHEUMATOL, V32, P811
[10]   Relations between personality and coping: A meta-analysis [J].
Connor-Smith, Jennifer K. ;
Flachsbart, Celeste .
JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY, 2007, 93 (06) :1080-1107